Leo Cancer Care Incorporated

Leo Cancer Care Incorporated develops and manufactures innovative radiation therapy systems designed to deliver cancer treatment in an upright patient position, challenging traditional supine radiotherapy conventions. The company specializes in two primary solution platforms: Marie, an award-winning upright particle therapy system named after Marie Curie, which integrates comprehensive imaging and treatment delivery for particle-based cancer treatment; and Grace, an emerging upright photon therapy solution combining an ultra-fast multileaf collimator (MLC), fan-beam CT scanner, and proprietary upright patient positioning system (currently pre-commercial). The company's core innovation centers on reintroducing upright positioning—reflecting natural human posture—to improve patient comfort, anatomical consistency, and clinical outcomes. Leo Cancer Care operates in the global oncology equipment market, serving cancer treatment centers and research institutions. The company has demonstrated clinical adoption through installations at leading cancer centers and collaborations with major medtech partners, including Fosun MedTech for particle therapy deployment in Asia. Additionally, Leo Cancer Care develops supportive care solutions, partnering with organizations like Xploro to create patient engagement tools such as Statue Quest, a game designed to support pediatric and adolescent patients undergoing radiation therapy. The company maintains a commitment to evidence-based clinical validation, as evidenced by recent landmark whitepaper publication on anatomical variations between supine and upright treatment positions.